000 | 02784nam a22005054u 4500 | ||
---|---|---|---|
001 | 10.1079/9781780646534.0000 | ||
003 | CABI | ||
005 | 20231004110349.0 | ||
007 | cr nn 008mam|a | ||
008 | 160926t2016||||xxu fs| |0|| 0|eng|| | ||
020 |
_a9781780646541 _qelectronic |
||
024 | 7 |
_a10.1079/9781780646534.0000 _2doi |
|
041 | _aeng | ||
245 | 0 | 0 |
_aIntellectual property issues in biotechnology _h[electronic resource] _cEdited by H. B. Singh, A. Jha, C. Keswani. |
250 | _a1 | ||
260 |
_aWallingford UK _bCABI _c2016 |
||
264 | 1 |
_aWallingford UK _bCABI _c2016 |
|
300 | _a264pp.; | ||
336 |
_atext _btxt _2rdacontent |
||
337 |
_acomputer _bc _2rdamedia |
||
338 |
_aonline resource _bcr _2rdacarrier |
||
347 |
_atext file _2rdaft |
||
347 | _bPDF | ||
490 | 1 | _aCABI Books | |
520 | _aThis book integrates a science and business approach to provide an introduction and an insider view of intellectual property issues within the biotech industry, with case studies and examples from developing economy markets. Broad in scope, this book covers key principles in pharmaceutical, industrial, and agricultural biotechnology within four parts.Part 1 details the principles of intellectual property and biotechnology. Part 2 covers plant biotechnology, including biotic and abiotic stress tolerance, GM foods in sustainable agriculture, microbial biodiversity and bioprospecting for improving crop health and productivity, and production and regulatory requirements of biopesticides and biofertilizers. The third part describes recent advances in industrial biotechnology, such as DNA patenting, and commercial viability of the CRISPR/Cas9 system in genome editing. The final part describes intellectual property issues in drug discovery and development of personalized medicine, and vaccines in biodefence.This book is an ideal resource for all postgraduates and researchers working in any branch of biotechnology that requires an overview of the recent developments of intellectual property frameworks in the biotech sector. | ||
653 | 0 | 0 | _abiotechnology |
653 | 0 | 0 | _acrop production |
653 | 0 | 0 | _adrug development |
653 | 0 | 0 | _aintellectual property rights |
653 | 0 | 0 | _apatents |
653 | 0 | 0 | _afood biotechnology |
653 | 0 | 0 | _agenetic engineering |
653 | 0 | 0 | _apharmacology |
653 | 0 | 0 | _agenetic improvement |
653 | 0 | 0 | _agenetic manipulation |
653 | 0 | 0 | _ahealth care |
700 | 1 |
_aSingh, H. B. _4edt |
|
700 | 1 |
_aJha, A. _4edt |
|
700 | 1 |
_aKeswani, C. _4edt |
|
776 | 0 | 8 |
_iPrinted edition: _z9781780646534 |
830 | 0 | _aCABI Books | |
856 | 4 | 0 | _uhttps://doi.org/10.1079/9781780646534.0000 |
856 | 4 | 0 | _uhttps://www.cabidigitallibrary.org/action/showBook?doi=10.1079%2F9781780646534.0000 |
942 | _cEB | ||
999 |
_c315786 _d315786 |